About Hologic, Inc. 
Hologic, Inc.
Pharmaceuticals & Biotechnology
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.
Company Coordinates 
Company Details
250 Campus Dr , MARLBOROUGH MA : 01752-3020
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 143 Schemes (45.93%)
Foreign Institutions
Held by 379 Foreign Institutions (33.61%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Stephen MacMillan
Chairman of the Board, President, Chief Executive Officer
Ms. Sally Crawford
Lead Independent Director
Mr. Charles Dockendorff
Independent Director
Mr. Scott Garrett
Independent Director
Dr. Ludwig Hantson
Independent Director
Mr. Namal Nawana
Independent Director
Revenue and Profits:
Net Sales:
1,024 Million
(Quarterly Results - Jun 2025)
Net Profit:
195 Million
Pharmaceuticals & Biotechnology
USD 17,704 Million (Small Cap)
21.00
NA
0.00%
0.13
16.75%
3.66






